Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jerome Ritz

Showing results (251-260 of 315) with videos related to

Pageof 32
Sort By:
Cytotherapy|December 13, 2016
Lack of impact of umbilical cord blood unit processing techniques on clinical outcomes in adult double cord blood transplant recipientsSarah Nikiforow, Shuli Li, Karen Snow, et al.
Blood|March 4, 2017
Pirfenidone ameliorates murine chronic GVHD through inhibition of macrophage infiltration and TGF-β productionJing Du, Katelyn Paz, Ryan Flynn, et al.
Blood Advances|January 10, 2024
Prophylactic maintenance with venetoclax/azacitidine after reduced-intensity conditioning allogeneic transplant for high-risk MDS and AMLJacqueline S Garcia, Haesook T Kim, H Moses Murdock, et al.
Cell Reports|November 10, 2021
Mapping the evolution of T cell states during response and resistance to adoptive cellular therapyPavan Bachireddy, Elham Azizi, Cassandra Burdziak, et al.
The New England Journal of Medicine|May 14, 2020
Personalized iPSC-Derived Dopamine Progenitor Cells for Parkinson's DiseaseJeffrey S Schweitzer, Bin Song, Todd M Herrington, et al.
Blood|March 14, 2022
Impact of diagnostic genetics on remission MRD and transplantation outcomes in older patients with AMLH Moses Murdock, Haesook T Kim, Nathan Denlinger, et al.
Blood Advances|September 1, 2019
Dose-escalated interleukin-2 therapy for refractory chronic graft-versus-host disease in adults and childrenJennifer S Whangbo, Haesook T Kim, Nikola Mirkovic, et al.
Blood Advances|July 21, 2019
Recurrent genetic HLA loss in AML relapsed after matched unrelated allogeneic hematopoietic cell transplantationMax Jan, Matthew J Leventhal, Elizabeth A Morgan, et al.
Biorxiv : the Preprint Server for Biology|November 26, 2025
Early persistence of recipient stem-cells and T-cell dysregulation are associated with relapse after transplant in AML/MDSNurefsan E Sariipek, Ksenia R Safina, Wesley S Lu, et al.
Blood|June 2, 2020
A multicenter phase 1 study of nivolumab for relapsed hematologic malignancies after allogeneic transplantationMatthew S Davids, Haesook T Kim, Caitlin Costello, et al.
Pageof 32

Showing results (251-260 of 315) with videos related to

Sort By:
Pageof 32
Cytotherapy|December 13, 2016
Lack of impact of umbilical cord blood unit processing techniques on clinical outcomes in adult double cord blood transplant recipientsSarah Nikiforow, Shuli Li, Karen Snow, et al.
Blood|March 4, 2017
Pirfenidone ameliorates murine chronic GVHD through inhibition of macrophage infiltration and TGF-β productionJing Du, Katelyn Paz, Ryan Flynn, et al.
Blood Advances|January 10, 2024
Prophylactic maintenance with venetoclax/azacitidine after reduced-intensity conditioning allogeneic transplant for high-risk MDS and AMLJacqueline S Garcia, Haesook T Kim, H Moses Murdock, et al.
Cell Reports|November 10, 2021
Mapping the evolution of T cell states during response and resistance to adoptive cellular therapyPavan Bachireddy, Elham Azizi, Cassandra Burdziak, et al.
The New England Journal of Medicine|May 14, 2020
Personalized iPSC-Derived Dopamine Progenitor Cells for Parkinson's DiseaseJeffrey S Schweitzer, Bin Song, Todd M Herrington, et al.
Blood|March 14, 2022
Impact of diagnostic genetics on remission MRD and transplantation outcomes in older patients with AMLH Moses Murdock, Haesook T Kim, Nathan Denlinger, et al.
Blood Advances|September 1, 2019
Dose-escalated interleukin-2 therapy for refractory chronic graft-versus-host disease in adults and childrenJennifer S Whangbo, Haesook T Kim, Nikola Mirkovic, et al.
Blood Advances|July 21, 2019
Recurrent genetic HLA loss in AML relapsed after matched unrelated allogeneic hematopoietic cell transplantationMax Jan, Matthew J Leventhal, Elizabeth A Morgan, et al.
Biorxiv : the Preprint Server for Biology|November 26, 2025
Early persistence of recipient stem-cells and T-cell dysregulation are associated with relapse after transplant in AML/MDSNurefsan E Sariipek, Ksenia R Safina, Wesley S Lu, et al.
Blood|June 2, 2020
A multicenter phase 1 study of nivolumab for relapsed hematologic malignancies after allogeneic transplantationMatthew S Davids, Haesook T Kim, Caitlin Costello, et al.
Pageof 32